Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients

ConclusionChanges in the CLND criteria in SN-positive patients and the approval of adjuvant therapies for stage III melanomas have significantly impacted Japanese melanoma medicine. Adjuvant therapy tended to prolong patient ’s RFS while omitting immediate CLND had no significant negative influence on it.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research